DNA evidence leads to arrest of Red Lion bank robber

Paul Smith Content Manager

11:35 a.m. EDT, September 4, 2012

YORK TOWNSHIP

July 27th 2011 robbery of Sovereign Bank 880 West Broadway Street, York Township. September 8th 2011 robbery of Sovereign Bank 880 West Broadway Street, York Township. January 3rd 2012 robbery of Peoples Bank 2587 Cape Horn Road, Windsor Township. June 14th 2012 attempted robbery of Sovereign Bank 880 West Broadway Street, York Township.

When the robber hit the Sovereign Bank in July and September of last year, he entered the bank with his face covered and wearing a sweat shirt turned inside out. He dropped the sweatshirt in a wooded area near the bank after the September robbery. That sweatshirt was recovered by police and sent to the Pennsylvania State Police Laboratory for DNA testing. On January 3rd, 2012, the same suspect robbed the Peoples Bank on Cape Horn Road in Windsor Township. The robber again had his face covered and wore a sweatshirt. The actor demanded money and fled the bank in a maroon Kia. A York Area Regional Police officer observed a car matching the suspect vehicle in Yoe Borough and pulled it over. The car was driven by Benjamin Pohl. When the officer did not find any evidence that linked Pohl to the bank robbery he was released. In the coming months, investigators focused on Pohl. The Sovereign Bank was robbed for the third time on June 14th, 2012. It was the same robber, same modus operandi- he again covered his face and wore a sweatshirt turned inside out. This time he jumped over the teller counter, but fled the bank before obtaining any cash. The suspect was seen entering a gold Honda sedan. Investigators knew Pohl owned a gold Honda sedan and responded to his Red Lion Borough address. This time, investigators obtained a search warrant for the residence and interviewed Pohl. They took a DNA sample and sent it to the Pennsylvania State Police DNA laboratory for comparison with the DNA collected from the gray sweatshirt. The DNA proved to be a match. Pohl subsequently admitted to committing five bank robberies.

Read more here:
DNA evidence leads to arrest of Red Lion bank robber

Posted in DNA

DNA tests confirm French tourist as Tiger Disco fire victim

Rally May Stall For Thai Stock Market

RTT News - Tuesday 4th September, 2012

9/4/2012 10:15 PM ET (RTTNews) - The Thai stock market has closed higher now in three straight sessions, collecting more than 20 points or 1.6 percent in that span. The Stock Exchange of Thailand ...

Asia News Network - Tuesday 4th September, 2012

The Bank of Thailand's Monetary Policy Committee is today expected to keep the policy rate at 3 per cent, where it has been since January, despite strong domestic demand and higher oil ...

Leader-Post - Tuesday 4th September, 2012

Vorayuth Yoovidhya, a grandson of late Red Bull founder Chaleo Yoovidhaya, is taken by a plain-clothes police officer for investigation Monday, Sept. 3, 2012 in Bangkok, Thailand. Vorayuth, believed ...

Wired News - Tuesday 4th September, 2012

Phi Phi Islands sit off the western coast of Thailand, floating like jewels in a turquoise sea, a picture-perfect image of a tropical getaway. Director Danny Boyle filmed his 2000 ...

The Globe and Mail - Tuesday 4th September, 2012

Read more:
DNA tests confirm French tourist as Tiger Disco fire victim

Posted in DNA

Protecting prime cuts

5 September 2012 Last updated at 01:54 By Michelle Warwicker Reporter, BBC Food

A new DNA test has been developed to allow retailers to authenticate Aberdeen-Angus beef, in a bid to protect its name and heritage.

"If you get a bright red chunk of beef, it may well look nice in a polystyrene tray, but it certainly won't eat very well," says Aberdeen-Angus breeder Geordie Soutar.

"But if you get one with a little bit of white fat round it and speckles through it, it will cook and eat sublimely."

The original Aberdeen-Angus was first bred in the early 19th Century in northeast Scotland, but now the cattle are bred in South America, Canada, the US and South Africa.

Now most Aberdeen-Angus cattle are cross-bred, and the amount of pure-bred Aberdeen-Angus beef on the market "is very very small", says Ron McHattie, chief executive of The Aberdeen-Angus Cattle Society.

This means breeders are keen to ensure no impostors lacking in fat and flavour sully Aberdeen Angus beef's reputation, because premium beef demands premium prices.

Waitrose sells Aberdeen-Angus beef sirloin steak for 24 per kg (6.00 per 250g pack), while the MacDonalds Brothers butchers in Perthshire, which is supplied by Geordie Soutar, charges 23.08 per kg of Aberdeen-Angus sirloin steak.

However cut-price chain Aldi recently introduced a range of "certified" Aberdeen-Angus beef, setting the cost of sirloin steak at 17.58 per kg (3.99 per 227g pack).

To ensure that such beef is legitimate, a DNA test has been developed for The Aberdeen-Angus Cattle Society by IdentiGEN, a company that provides DNA technology to the food industry.

Continue reading here:
Protecting prime cuts

Posted in DNA

DNA center stage in killing of 80-year-old East Little Havana woman

The trial to solve the December 2000 murder of an 80-year-old woman will be decided by blood.

Victor Guzman, 39, is charged with the first degree murder of Severina Dolores Fernandez a killing that was as mysterious as it was gruesome at the time of the crime. The only evidence connecting Guzman to the murder is a DNA sample taken from the scene.

In his opening statement on Tuesday, state prosecutor Scott Warfman described the scene in Fernandezs otherwise tidy apartment in East Little Havana.

Police found her body in a puddle of blood on her bed, naked, with 58 stab wounds. Blood splatters stained the armrest of a chair, a couch cushion, the dresser, the window and the sink.

The trial began on an emotional note, with the prosecution calling Isabel Reyes, the victims niece.

Reyes spoke affectionately of her aunt and the routine that she kept every afternoon. Tia Lola, as Reyes called her, would go outside every day at 5 p.m. to get her newspaper, come upstairs, fold the paper to the crossword and get a bowl of sherbet to eat while she solved it.

When police found her body on the afternoon of Dec. 9, 2000, the tub of sherbet was still melting on the counter. Warfman showed the jury two graphic photos of the crime scene, which he said looks like finger-painting, theres so much blood.

But not all of it came from the victim.

Fernandez managed to fight off her attacker enough to draw his blood, leaving behind DNA evidence that didnt match existing police records.

Some two years later, the same DNA turned up in the rape of a 12-year-old girl in Miami Beach, but police had no idea whose DNA marked both heinous crimes.

Read this article:
DNA center stage in killing of 80-year-old East Little Havana woman

Posted in DNA

Danforth Plant Science Center hosts 14th Annual Fall Symposium

Public release date: 4-Sep-2012 [ | E-mail | Share ]

Contact: Melanie Bernds mbernds@danforthcenter.org 314-587-1647 Donald Danforth Plant Science Center

ST. LOUIS, MO, September 4, 2012 The Donald Danforth Plant Science Center will be hosting its 14th annual Fall Symposium from Wednesday, September 26th Friday, September 28th, 2012. This year's symposium will feature lectures by influential experts from across the world who will present on a wide range of topics on cutting-edge science. This year's theme will focus on synthetic and systems level explorations in biology that are establishing fundamental emergent properties of complex biological systems.

"The annual symposium is an opportunity for a diverse group of scientists from private research, industry and universities to interact and learn from state-of-the-art talks on focused topics within biology," said Doug Allen, USDA Research Scientist, Assistant Member, Donald Danforth Plant Science Center who is organizing this year's event. "This is another example of how the Center works to enhance science in the St. Louis region."

Systems biology uses quantitative experimental approaches and computational modeling to understand how a multitude of components work together as a system to enable living systems to function. In addition, synthetic biology extends this understanding by redesigning and manipulating the capabilities of a biological system to achieve new and different goals. The Center's symposium will explore how systems and synthetic biology are complementary and facilitate the engineering of living systems with new functions and properties.

"The three day symposium breaks into four concentrated sessions with multiple speakers discussing gene networks, rewiring, metabolism, and genomes evolution" said Dr. Todd Mockler, the Geraldine and Robert Virgil Distinguished Investigator at the Danforth Center and Symposium organizer. "The themed sessions give attendees a variety of comprehensive lectures relating to synthetic and systems biology."

Registration will remain open until September 19th, 2012. The registration fee includes access to all sessions, social events, breaks and meals as indicated in the program. For a list of the esteemed speakers and topics please visit http://www.danforthcenter.org/fall_symposium/speakers.asp.

The registration fee for post-doctoral fellows, technicians or equivalent is reduced. Graduate students are welcome to participate for free. To register, please visit http://www.danforthcenter.org/symposium_registration/.

###

Sponsors

Go here to see the original:
Danforth Plant Science Center hosts 14th Annual Fall Symposium

HORIBA Medical Announces Success of Online Training for Haematology Analysers

'Virtual' classrooms enhance staff training at Spire Healthcare

Northampton, UK - The implementation of HORIBA Medical UK's online training programme for its haematology analysers has proven to be a great success at Spire Pathology Services. HORIBA Medical's ABX Pentra 80 haematology analysers have played a major role in helping Spire Pathology Services to process the more than 1.8 million samples that are tested yearly in its 18 laboratories for hospitals within the Spire Healthcare Group (the second largest group of private hospitals across the UK), as well as external customers, including the independent and NHS sectors.

HORIBA Medical's ABX Pentra 80 haematology analysers fulfil all the requirements of Spire's busy pathology labs, however one of the biggest challenges lies in ensuring all appropriate personnel are fully trained and certified to use the analysers. Consequently, Spire adopted the HORIBA e-Learning Portal (HeLP) as a complement to its on-site and classroom-based learning. As a computer-based, online programme, this not only improves the accessibility of training for staff working shifts and on-call, but also facilitates a multi-disciplinary approach to blood analysis. As Spire's staff hold a diverse range of medical and laboratory expertise, the user-friendly, modular courses ensure that differing learning needs can be met.

The HeLP e-learning programme, written and designed in-house by HORIBA Medical team experts, was adapted for Spire's individual needs by working with Linda Joyce, Manager at Spire Pathology Services' Portsmouth Laboratory. "The ABX Pentra 80 haematology analysers tick all the boxes in terms of the blood analysis requirements of our pathology laboratories, but it is always a challenge to make sure that all our staff, from a range of specialities, are well-trained to use the analysers. The HeLP online training programme provides the ideal solution," said Linda Joyce. As an administrator of online learning at Spire Pathology Services, Linda Joyce is notified by email when personnel in the countrywide pathology laboratories have successfully completed the course, making it easy for her to keep up-to-date with who has received the training.

According to Linda Joyce, one of the key benefits of the e-learning programme was the flexibility to adapt it to the requirements of the pathology laboratories. "HORIBA Medical were very good at working with us to adapt the online tool to our needs. I worked personally with them to set up the package, where certain aspects were changed to tailor the learning programme to the requirements of our personnel. For example, one of the areas we needed more tuition on was for a statistical measurement of population means: the package was modified to include this."

HeLP fully supports a multi-disciplinary use of the HORIBA haematology analysers. For example, the online tool ensures that non-biomedical scientists (BMS) can be trained to the appropriate level necessary to use the blood analyser. "HORIBA Medical have even designed a haematology course for beginners to bring medical laboratory assistants and biochemists unfamiliar with blood work, up to speed," added Linda Joyce. "We also have a two-tiered learning programme for the analysers; Level 1 is for basic users such as non BMS staff and Level 2 is more advanced, for BMS staff. This means learning is adapted specifically to the users' needs."

Spire Pathology Services' professional service dictates that all personnel must hold certificates of competency in order to use the haematology analysers. Upon the successful completion of the e-learning courses, certificates are produced which carry a Continued Professional Development (CPD) code accredited from the Institute of Biomedical Sciences. "Ensuring that our entire team are working at a high level of competency is vital to us at Spire and thanks to HORIBA's online training programme this is now possible. The design of an e-learning course tailored specifically to our needs is a reflection of our continued excellent working relationship with HORIBA," commented Linda Joyce.

For more information please visit http://www.horiba.com/uk/medical

ABOUT HORIBA Medical - UK: http://www.horiba.com/uk/medical

Resulting from nearly 30 years of understanding and meeting its customers' exacting individual needs, the HORIBA Medical team holds a wealth of expertise in haematology, and increasingly in clinical chemistry. Consequently, HORIBA Medical has become a well-respected and renowned specialist in the design and manufacture of automated in vitro diagnostic systems for haematology and chemistry analysis.

View post:
HORIBA Medical Announces Success of Online Training for Haematology Analysers

Frontline health staff’s job cut warning

PATHOLOGY Queensland is preparing to shed staff as part of $25 million in budget cuts, and employees have been warned "being frontline offers no protection".

An email from Pathology Queensland's principal chief scientist for haematology, Dominic Burns, outlines government plans for the organisation to become "more efficient with less resources".

"There is a head count imperative as well as a budget imperative," he says in the email.

"The budget would be difficult to achieve without reducing staff."

The email, obtained by The Courier-Mail, says if a role is no longer required, human resources will work with affected employees on the possibility of placement in another position.

A video conference with staff is planned for later this week, when further details are expected to be revealed.

Mr Burns' email refers staff to Queensland Health's Employee Assistance Program, a free counselling service, given "there may be considerable stress and uncertainty for everyone".

He said it was possible some services may be devolved to the 17 hospital and health service districts.

Public health expert Mike Daube, professor of health policy at Curtin University in Western Australia, said yesterday that devolution of services to the districts could be "expensive or a recipe for disaster - possibly both".

"There is no way that 17 boards will have the expertise to address all the issues and problems they will face," Professor Daube said.

Read the rest here:
Frontline health staff's job cut warning

Parents Failing To Make Informed Decision About Right Nutrition For Children

September 04, 2012 18:08 PM

Parents Failing To Make Informed Decision About Right Nutrition For Children

By Wan Shahara Ahmad Ghazali

KUALA LUMPUR, Sept 4 (Bernama) -- A child needs proper nutrition for a healthy and adequate development as well as strong physical growth.

A child's normal development and physical growth are crucial, particularly during infancy and up to the time he or she is around seven years old.

Hence, healthy nutrition is vital for a growing child and parents should ensure that they play an instrumental role in this aspect.

A recent study indicates that in the bid to ensure that their child gets all the essential nutrients, young mothers resort to using formula milk or growing up milk (GUM) for meeting the nutritional needs of their infants.

STUDY INDICATORS

The Nutrition Society of Malaysia (NSM), in collaboration with Abbott Nutrition, carried out a recent study, which included 300 mothers who have children below three years of age.

The study shows that several factors influence a young mothers' choice of GUM.

Read the rest here:
Parents Failing To Make Informed Decision About Right Nutrition For Children

New long-term antimicrobial catheter developed

Public release date: 3-Sep-2012 [ | E-mail | Share ]

Contact: Laura Udakis l.udakis@sgm.ac.uk 44-079-908-26696 Society for General Microbiology

A novel antimicrobial catheter that remains infection-free for up to twelve weeks could dramatically improve the lives of long-term catheter users. The scientists who have developed the new technology are presenting their work at the Society for General Microbiology's Autumn Conference at the University of Warwick.

Researchers at the University of Nottingham have developed a catheter that can kill most urinary bacteria, including most strains of Proteus bacteria the most common cause of catheter infections. Importantly the antimicrobial catheter retains its activity for between six to twelve weeks, making it suitable for long-term use, unlike existing commercial anti-infection catheters.

Urinary catheters are commonly used to manage incontinence in the elderly or individuals who have suffered long-term spinal cord injury. All catheters become infected after a couple of weeks and Proteus bacteria are responsible for up to 40% of these infections. The bacterium sticks to catheter surfaces and breaks down urea, causing the pH of urine to rise. This causes deposits of mineral crystals in the catheter which blocks it, preventing drainage. If unnoticed, catheter blockage can lead to kidney and bloodstream infections, which ultimately may result in potentially fatal septic shock.

This new antimicrobial catheter has significant advantages over existing solutions, explained Dr Roger Bayston who is leading the development. "Commercial 'anti-infection' catheters are active for only a few days and are not suitable for long-term use. There is an urgent need for an antimicrobial catheter that is suitable for long-term use. Our catheter uses patented technology that does not involve any coatings which extends its antimicrobial activity. The process involves introducing antimicrobial molecules into the catheter material after manufacture, so that they are evenly distributed throughout it, yet can move through the material to replenish those washed away from the surface."

There are 100 million catheter users worldwide whose lives can be severely disrupted by illness from repeat infections and side-effects from antibiotics. "The catheter technology has proven benefit in other medical settings and has the potential to be the solution to recurrent infections in long-term catheter users, which will improve quality of life of these individuals. In addition, reducing the need to frequently change catheters and treat infections would represent huge financial savings to the NHS," explained Dr Bayston.

###

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Read more here:
New long-term antimicrobial catheter developed

Monster And Viacom Introduce Monster DNA Headphones And A New Alliance To Support Music Culture

NEW YORK, Sept. 4, 2012 /PRNewswire/ --Monster, the world's leading manufacturer of high-performance headphones and electronic accessories, and Viacom, home to the world's premier entertainment brands, today announced a global alliance for the launch of a new audio brand Monster DNA. With Monster's latest advancement in sound engineering, Monster DNA headphones bring music listeners a new sound that is as powerful and striking as the bold design of the headphone itself. More than a headphone, Monster DNA will look to serve today's music listener and music artists with a focus on music sharing, music community, and social awareness reaching the music entertainment community globally through an exclusive integrated campaign across Viacom music and entertainment brands worldwide including CMT, COMEDY CENTRAL, Logo, MTV, MTV2, mtvU, SPIKE, Tr3s, VH1 and VH1 Classic.

(Photo: http://photos.prnewswire.com/prnh/20120904/NY67054 )

Rooted in the technology behind music, Monster has been dedicated to improving the music listening experience, from its development of high-performance audio cable for audiophiles, to professional recording and instrument cables for musicians. Recently, the company changed the way people think about what a headphone can sound like when it engineered the sound of the popular Beats by Dr. Dre headphones.

Said Noel Lee, The Head Monster: "We're excited about what we have accomplished with next generation sound with Monster DNA. It's the evolution of what a headphone can look and sound like. Sonically, they completely kick ass yet still have refined sound qualities that all music lovers can appreciate."

Viacom will provide a global platform for the Monster DNA headphones through its diverse entertainment brands, which continue to innovate, create culture and connect with young audiences at the intersection of music and entertainment. "Just like Viacom's brands, Monster DNA headphones are designed to reflect the creativity and confidence of young people," said Jeff Lucas, Head of Sales, Music and Entertainment for Viacom. "Through this partnership, we're plugging Monster in to the deep connection we have with our young audiences, and giving our fans a new way to experience sound and express originality."

Monster DNA is Next Generation EverythingDesigned with both the music and fashion consumer in mind, Monster took a very aggressive approach to evolve its audio signature, the technologies that make it possible, the not-square-or- round triangle speaker housing, and its fashion forward two-tone color design. Extensive design considerations included advanced ear cushion design and lightness for overall better ear comfort than similar on-ear headphones. "We tried to think of everything we could do to make Monster DNA better than anything out there for today's extensive music listener. We even included a nifty buddy jack to share what you're listening to, something we thought people might want to do but haven't thought about," added Lee.

Music Isn't the Only Thing That Matters Music is a very powerful platform, building on the message that music matters, Monster and Viacom want to ensure that Monster DNA helps advance important pro-social causes that resonate with young music fans. The unprecedented alliance will benefit from the global marketing power of Viacom's brands and connect to many of its pro-social campaigns, including the MTV Staying Alive Foundation, SPIKE's Hire a Vet and the VH1 Save the Music Foundation.

Monster DNA to Debut at 2012 MTV Video Music AwardsThe Monster DNA campaign will officially launch at the 2012 MTV Video Music Awards, airing live from Los Angeles on Thursday, September 6 at 8:00 p.m. ET/PT. The new headphones will be integrated into several elements, and VMA performing and presenting music artists and celebrities will have the first-hand look and sound experience when they receive special chrome versions, a nod to MTV's moon man. Monster DNA will also be integrated into the 2012 MTV EMA, airing globally from Frankfurt, Germany on Sunday, November 11th.

Monster DNA in Stores Soon Monster DNA will be available in the U.S. in September and in Europe in October at the following retailers: Apple stores worldwide, Best Buy and its Global Subsidiaries (Future Shop) and HMV Europe. They will be offered in seven different versions, including On-Ear models in Black, White, Cobalt Blue and Perfect Teal for a suggested retail price of $199.95, as well as Black and White In-Ear versions (SRP:$99.95).

ABOUT MONSTER Monster was founded over 30 years ago by Head Monster Noel Lee, who was recently honored with the prestigious Plus X Award: Lifetime Achievement Award, as a company dedicated to creating products that enhance the sound quality of music. The company engineered the sound of the acclaimed Beats by Dr. Dre headphones, and has become the world's leading manufacturer of high-performance, sonically superior headphones, all of which feature the company's Pure Monster Sound. Monster is also the world's leading manufacturer of advanced connectivity solutions for high-performance home entertainment, audio, home cinema, computer and gaming as well as a leading innovator in the field of mobile accessories and professional audio. The company also provides high-performance AC power line conditioning and protection products for audio/video systems, as well as energy-saving power products. Monster continues to lead in innovation with over 300 U.S. and international patents and dozens pending, offering more than 4,000 products in over 134 countries worldwide.

See original here:
Monster And Viacom Introduce Monster DNA Headphones And A New Alliance To Support Music Culture

Posted in DNA

Jonathan DiVincenzo Joins Enzymatics as President and Chief Executive Officer

BEVERLY, Mass.--(BUSINESS WIRE)--

Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced the appointment of Jonathan DiVincenzo as President and Chief Executive Officer. Mr. DiVincenzo brings more than 20 years of industry experience to the role having previously served as Corporate Officer of Millipore Corporation andPresident of its Bioscience Division. Mr. DiVincenzo joins Enzymatics to continue the growth fueled by the immense scientific skill set, drive and ambition of the Companys workforce.

Jon is a visionary leader with a strong track record of building global businesses serving the life science industry," said Ian Ratcliffe, Chairman of Enzymatics Board of Directors. "His experience and capabilities in bringing new technologies to global markets make him uniquely qualified to lead Enzymatics through its next wave of growth."

Enzymatics co-founders Stephen Picone and Christopher Benoit commented, Enzymatics has evolved into a thriving business from a startup in 2007, growing to approximately 100 employees in just five years. We welcome Jon to the Enzymatics family, and with his extensive commercial and strategic experience, we will continue to build Enzymatics as the leading global supplier of high quality reagents and services to the rapidly expanding molecular genetics industry. Stephen Picone and Chris Benoit are remaining at the Company in active roles under the new titles, Chief Strategy Officer and Chief Commercial Officer, respectively.

Mr. DiVincenzo has held several key leadership positions during his 18-year tenure at Millipore Corporation (now Merck Millipore).As the President of the Companys Bioscience Division, Jon led 1200 employees and grew the division to over $600 million of revenues. Prior to that he served as Vice President of Global Sales and Service and as Vice President of Marketing and R&D. For several years, he also held senior marketing and product management positions within Millipores Lab Water business (which later became part of the Bioscience Division) in Paris. Before Millipore, Jon worked for Orion Research (now part of ThermoFisher Scientific) as Product Manager and Technical Support Engineer and for General Electric Corporation in thermodynamics engineering. Jon holds a Bachelor of Science degree in Mechanical Engineering from Northeastern University in Boston. He is a member of the Northeasterns College of Engineering Advisory Board and Board of Directors of the Analytical and Life Science Systems Association (ALSSA).

About Enzymatics

Enzymatics is a leading provider of molecular biology reagents and manufacturing services that delivers unrivaled quality, consistency, and value to the commercial genomic sciences community. The company manufactures in the USA under ISO 13485 certification, is focused on building long-term partnerships, and leverages internal and external innovation to commercialize breakthrough technologies. http://www.enzymatics.com

Photos/MultimediaGallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394385&lang=en

MULTIMEDIA AVAILABLE:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394385&lang=en

See the article here:
Jonathan DiVincenzo Joins Enzymatics as President and Chief Executive Officer

GLOBAL BIOENERGIES nominated as one of the five most innovative European biotech SMEs by EuropaBio

EVRY, France--(BUSINESS WIRE)--

Global Bioenergies (ALGBE.PA), an industrial biology company developing sustainable routes to light olefins, has been nominated as one of the five most innovative European biotech SMEs by EuropaBio, representing more than 1800 European companies.

EuropaBio, the principal organization to represent more than 1800 of Europes biotechnology companies, has communicated the choice of its expert panel for the Most Innovative EU Biotech SME Award 2012 in the press release which can be found under http://www.europabio.org/sme/press/who-are-europes-5-most-innovative-biotech-smes.

The award ceremony will be held on September 19th in the European Parliament by Commission Vice President Antonio Tajani, Commissioner for Industry & Entrepreneurship.

Marc Delcourt, co-founder and CEO of Global Bioenergies, comments: We are very honored by the choice of the expert panel of this prestigious biotechnology award, in particular because it was open to all European biotechnology companies acting in fields as diverse as pharmaceuticals, diagnostics, plant science, environment and industrial biology. We would like to thank EuropaBio for their recognition of our unique synthetic biology-based approach to convert renewable resources into light olefins, the core molecules of the petrochemical industry, and more generally for their support to the emerging industrial biology community.

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepares the phase dedicated to pilot testing. The company is also looking to replicate this success with other members of the gaseous olefins family (propylene, ethylene, linear butylenes, butadiene), key molecules at the heart of petrochemical industry. Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 ALGBE).

Should you like to be kept informed, subscribe to our news feed on http://www.global-bioenergies.com

See the original post here:
GLOBAL BIOENERGIES nominated as one of the five most innovative European biotech SMEs by EuropaBio

Research and Markets: Biochemical Pathways. An Atlas of Biochemistry and Molecular Biology

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/np8lcc/biochemical_pathwa) has announced the addition of John Wiley and Sons Ltd's new book "Biochemical Pathways. An Atlas of Biochemistry and Molecular Biology" to their offering.

Covering a wide range of subject matter, including biochemistry, molecular and cell biology, medicine, chemistry, and allied health, Biochemical Pathways is a full-color, easy-to-use resource for students and professionals. This information-packed reference features a unique summary of biochemical pathways based on the well-known Biochemical Pathways chart. Included is descriptive information about properties such as enzymes, chemicals, proteins, and DNA, all of which act together to create an elaborate chain that drives all biological functions. Completely updated, this new edition continues to play a valuable role in this important scientific field.

Key Topics Covered:

Chapter 1. Introduction and general aspects, chemistry and physical chemistry

Chapter 2. The cell and its contents: Enzymes, nucleic acids, and polymeric carbohydrates and lipids

Chapter 3. General metabolism in animals, plants and bacteria

Chapter 4. Protein biosynthesis, modification and degradation

Chapter 5. Viruses

Chapter 6. Transport systems

Read more here:
Research and Markets: Biochemical Pathways. An Atlas of Biochemistry and Molecular Biology

Global Beauty Industry Challenged, as World's Strongest Antioxidant MitoQ® Hits Market

PARIS, September 4, 2012 /PRNewswire/ --

The world's most potent antioxidant to date MitoQ, proven 1000 times stronger than CoQ[10], will become available to the public this September 2012. MitoQfacial cream is set to challenge the international industry with a new level of efficacy

Dubbed next generation CoQ[10], MitoQ is scientifically proven 1000 times more powerful in protecting skin cells from oxidative damage than idebenone or CoQ, both utilised extensively in the world's best selling anti-aging products. The September 2012 launch of MitoQ facial cream sets a new standard for those seeking rejuvenation, through science and skin health. The MitoQ molecule, the key ingredient in the MitoQ cream is a recognised and patented invention. It is the only product available that can penetrate mitochondrial membrane, where it delivers powerful antioxidant.

(Photo: http://photos.prnewswire.com/prnh/20120904/559249 )

The major scientific breakthrough: the active potency of MitoQ to eliminate oxidative damage caused by free radicals, has been acknowledged by the highest scientific authorities. Studies and articles have been published in renowned scientific peer-reviewed journals, including: Annals of the New York Academy of Sciences[1] and the Journal of Biological Chemistry.[2]

Antipodean Pharmaceuticals CEO Dr Kenneth Taylor says: "We identified the breakthrough as being potentially huge amongst the globally aging population looking for aging solutions. Our topical skincare cream MitoQ accelerates the skin cells' natural renewal cycle, with rejuvenation evidenced in the outward skin brightening and a clearer more even complexion developing with the reduction of fine lines and fading any pigments. It's bio-tech at the beauty counter."

MitoQ facial cream is the result of over ten years of research and development with costs recorded at over $US30 million-to-date. It is the work of Dr Michael Murphy, Mitochondrial Biology Unit, Cambridge and Professor Rob Smith Chemistry Department, Otago University, New Zealand. In a cutting-edge development a unique electrostatic penetration system is used to deliver antioxidant to the cells mitochondria. Neutralising free radicals where they are produced. Thus, stopping the skin aging process and healing prior damage.

MitoQ re-densifies skin, healing and preventing fine lines and wrinkles. MitoQ fades scars, brown spots and skin discoloration. Preview users show impressive results as increased collagen re-formats and strengthens the skin's structure.

Real rejuvenation has become possible. With 20-year international patents in place there cannot be an over-the-counter product that uses this MitoQ exclusive technology in the foreseeable future.

Priced at (50ml) US$185 (approx 145) MitoQ facial cream will initially hit the global beauty market on http://www.MitoQ.com, this September 2012.

Link:
Global Beauty Industry Challenged, as World's Strongest Antioxidant MitoQ® Hits Market

Proteonomix Engages Numoda Corporation for Clinical Trial Services

PARAMUS, N.J.--(BUSINESS WIRE)--

Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an agreement with a leading provider of global clinical trial technologies and services, Numoda Corporation.

Our engagement of Numoda is an important step in effectively and efficiently advancing the development of our proprietary therapeutics, said Proteonomix Chief Technology Officer Steven Byle. Numoda has a proven, innovative approach for assisting life sciences companies like Proteonomix to move through the clinical development process. We anticipate collaborating with the Numoda team on the Phase 1 clinical trial with our mobilization technology UMK-121 in patients with end-stage liver disease (ESLD).

On August 14, 2012, Proteonomix announced that the U.S. Food and Drug Administration had granted permission to the Company to initiate a Phase 1 clinical trial to evaluate UMK-121 in patients with ESLD.

Numoda Corporation

Philadelphia-based Numoda Corporation is a leading provider of clinical trial information and logistics services to promising life sciences companies. Numoda's services strengthen the business case for new therapies by ensuring efficient deployment of funds and immediate reporting for early assessment of progress to improve conditions for the acquisition of funding, licensing and partnering money for future success. The business offerings include business evaluation, budget projections and oversight, in conjunction with comprehensive management of clinical trials, patented information systems, logistics management and reporting tools with early visibility. Visit Numoda Corporation at http://www.numoda.com.

About Proteonomix, Inc.

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Proteonomix family of companies includes Proteoderm, StromaCel, PRTMI and THOR Biopharma. Proteodermis a wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel develops therapeutic modalities for the treatment of cardiovascular disease and plans to file an IND application for treatment of patients who have suffered post-myocardial infarction. Proteonomix Regenerative Translational Medicine Institute, Inc. (PRTMI) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Additional information is available at http://www.proteonomix.com and http://www.proteoderm.com.

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Here is the original post:
Proteonomix Engages Numoda Corporation for Clinical Trial Services

Dining services adds nutrition facts to daily menu

Written by Alyssa Morlacci Monday, 03 September 2012 18:24

With nutrition facts now available for Dining Services daily menus a health initiative thats new this semester its easier than ever for campus diners to choose which food items to stock up on and which to leave behind.

Before classes began, Kent State executive chefs compiled nutrition facts for the menus that change daily at Eastway Cafe and Kent Market, and the facts are listed at those locations, said Dining Services director Richard Roldan. Nutrition facts for more locations and items that are served every day are available on the Dining Services website.

We talk about nutrition and people wanting to understand what they eat, Roldan said. So for us it was important that everything was out there and the information was available.

On average, students gain three to 10 pounds during their first two years of college, and most students gain that weight during their first semester, said nutrition outreach coordinator Tanya Falcone.

There is a misconception that eating healthy on campus is impossible, she said, but with the facts, students have more choices than they might realize.

1. Keep meals at a maximum of 500 calories and 15 grams of fat. This is based on the 2,000 calorie diet that plans for three meals and two smaller snacks.

2. Split meals that have larger amounts of calories and grams of fat with a friend or eat half and save the rest for later.

3. Look for items that are grilled instead of fried.

4. Eat healthy foods during a craving. For example, instead of eating three pieces of pizza, have one piece and a salad.

Go here to see the original:
Dining services adds nutrition facts to daily menu

The eyes have it: Men do see things differently to women

Public release date: 3-Sep-2012 [ | E-mail | Share ]

Contact: Dr. Hilary Glover hilary.glover@biomedcentral.com 44-020-319-22370 BioMed Central

The way that the visual centers of men and women's brains works is different, finds new research published in BioMed Central's open access journal Biology of Sex Differences. Men have greater sensitivity to fine detail and rapidly moving stimuli, but women are better at discriminating between colors.

In the brain there are high concentrations of male sex hormone (androgen) receptors throughout cerebral cortex, especially in the visual cortex which is responsible for processing images. Androgens are also responsible for controlling the development of neurons in the visual cortex during embryogenesis, meaning that males have 25% more of these neurons than females.

Researchers from Brooklyn and Hunter Colleges of the City University of New York compared the vision of men and women aged over 16 from both college and high school, including students and staff. All volunteers were required to have normal color vision and 20/20 sight (or 20/20 when corrected by glasses or contact lenses).

When the volunteers were required to describe colors shown to them across the visual spectrum it became obvious that the color vision of men was shifted, and that they required a slightly longer wavelength to experience the same hue as the women. The males also had a broader range in the center of the spectrum where they were less able to discriminate between colors.

An image of light and dark bars was used to measure contrast-sensitivity functions (CSF) of vision; the bars were either horizontal or vertical and volunteers had to choose which one they saw. In each image, when the light and dark bars were alternated the image appeared to flicker.

By varying how rapidly the bars alternated or how close together they were, the team found that at moderate rates of image change, observers lost sensitivity for close together bars, and gained sensitivity when the bars were farther apart. However when the image change was faster both sexes were less able to resolve the images over all bar widths. Overall the men were better able to resolve more rapidly changing images that were closer together than the women.

Prof Israel Abramov, who led this study commented, "As with other senses, such as hearing and the olfactory system, there are marked sex differences in vision between men and women. The elements of vision we measured are determined by inputs from specific sets of thalamic neurons into the primary visual cortex. We suggest that, since these neurons are guided by the cortex during embryogenesis, that testosterone plays a major role, somehow leading to different connectivity between males and females. The evolutionary driving force between these differences is less clear."

###

See more here:
The eyes have it: Men do see things differently to women

GSW, Chehaw collaborate in conservation biology

Albany Chehaw Parks Education and Animal Care Department and Georgia Southwestern State University (GSW) Biology Department are to begin a new partnership in conservation biology. For the first time during fall semester 2012, the University and the Zoo will collaborate in teaching a class in Zoo Animal Care and Maintenance.

It has always been a dream of mine to see Chehaw used to engage students as a learning institution, said Doug Porter, executive director for Chehaw. This new and exciting partnership will not only be beneficial to the Park and the University but to the greater community of Southwest Georgia.

The class will be a hands-on practice-oriented course in which more time will be spent working at the Zoo than sitting in the classroom. The goals of the course are to introduce students with a passion for animal husbandry and conservation to a career in zoo keeping. The course will cover the basics in zoo keeping, including, animal handling techniques, management, nutrition, breeding, behavior enrichment, exhibit design, zoo administration and public education of the major animal groups.

I am looking forward to getting this program off of the ground, shared Ian Brown, Ph.D., associate professor of biology at GSW. The chance to have our students working in this field as undergraduates will give them the experience that they will need when applying for future jobs in conservation.

The relationship between Chehaw Park and GSW has slowly gained momentum over the past eight years. As early as 2004, biology students began visiting the zoo to conduct behavioral observation laboratories on various animals such as the colobus monkey, flamingos, lemurs, meerkats and cheetahs. In recent years the zoo has used these student assignments as supporting material in grant applications. To date, three GSW biology majors have been hired as summer program instructors and another three have volunteered as zoo keeper assistants.

Zoo Animal Care and Maintenance students will spend their classroom time studying the theoretical aspects of the husbandry and welfare of non-domesticated animals in captivity and the logistics of zoological and conservation park operation. The overall focus in the classroom will be on the role that modern zoos must play in habitat and species conservation.

At Chehaw, the students will work alongside zoo professionals to learn the practical details of this important field. They also will be spending time with some of the Zoos leadership team, the Zoo director, the Zoo curator and Education coordinator to gain valuable insight into the inner workings of an AZA (Association of Zoos and Aquariums) -accredited Zoo.

This first class is being made possible through the willingness of university faculty and zoo personnel to take on additional workloads. In the future it is hoped that this initial class will grow into an entire zoo technology program with an emphasis in threatened species conservation.

The course instructors realize that modern Zoological and Conservation Parks and Aquariums utilize cutting edge technology to care for and breed many hundreds of animal species. Therefore most parks now require that their staff hold the minimum of a two-year and preferably a four-year degree in biology, animal husbandry or related field.

These new demands have opened up unique university-zoo collaboration opportunities to provide the requisite qualified zoo animal care personnel. Furthermore, in the near future a greater demand for zoos and aquariums is predicted, as their roles in animal conservation become increasingly more valuable.

Original post:
GSW, Chehaw collaborate in conservation biology

Research and Markets: DNA Sequencing – Technologies, Markets and Companies – Updated 2012 Edition

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/k3m8pf/dna_sequencing_t) has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.

Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2011 is described with estimates for 2016 and 2021. Various methods and factors on which market estimates depend are described briefly. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.

The report includes profiles of 100 companies involved in sequencing and their 101 collaborations. The report text is supplementd by 32 tables, 12 figures and 275 selected references to the literature.

Key Topics Covered:

1. Introduction

2. DNA Sequencing Technologies

3. Comparative Analysis of Sequencing Technologies

4. Research Applications of Sequencing

Original post:
Research and Markets: DNA Sequencing - Technologies, Markets and Companies - Updated 2012 Edition

Posted in DNA